Association of pulmonary vein isolation and major cardiovascular events in patients with atrial fibrillation
Year: 2022
Type: article
Study design: Observational Study
Abstract: BACKGROUND: Patients with atrial fibrillation (AF) face an increased risk of adverse cardiovascular events. Evidence suggests that early rhythm control including AF ablation may reduce this risk. METHODS: To compare the risks for cardiovascular events in AF patients with and without pulmonary vein isolation (PVI), we analysed data from two prospective cohort studies in Switzerland (n = 3968). A total of 325 patients who had undergone PVI during a 1-year observational period were assigned to the PVI group. Using coarsened exact matching, 2193 patients were assigned to the non-PVI group. Outcomes were all-cause mortality, hospital admission for acute heart failure, a composite of stroke, transient ischemic attack and systemic embolism (Stroke/TIA/SE), myocardial infarction (MI), and bleedings. We calculated multivariable adjusted Cox proportional-hazards models. RESULTS: Overall, 2518 patients were included, median age was 66 years [IQR 61.0, 71.0], 25.8% were female. After a median follow-up time of 3.9 years, fewer patients in the PVI group died from any cause (incidence per 100 patient-years 0.64 versus 1.87, HR 0.39, 95%CI 0.19-0.79, p = 0.009) or were admitted to hospital for acute heart failure (incidence per 100 patient-years 0.52 versus 1.72, HR 0.44, 95%CI 0.21-0.95, p = 0.035). There was no significant association between PVI and Stroke/TIA/SE (HR 0.94, 95%CI 0.52-1.69, p = 0.80), MI (HR 0.43, 95%CI 0.11-1.63, p = 0.20) or bleeding (HR 0.75, 95% CI 0.50-1.12, p = 0.20). CONCLUSIONS: In our matched comparison, patients in the PVI group had a lower incidence rate of all-cause mortality and hospital admission for acute heart failure compared to the non-PVI group. GOV IDENTIFIER: NCT02105844, April 7th 2014.
Source: Clinical Research in Cardiology
Authors: Marc Girod, Michael Coslovsky, Stefanie Aeschbacher, Christian Sticherling, Tobias Reichlin, Laurent Roten, Nicolas Rodondi, Peter Ammann, Angelo Auricchio, Giorgio Moschovitis, Richard Kobza, Patrick Badertscher, Sven Knecht, Philipp Krisai, Andrea Marugg, Helena Aebersold, Elisa Hennings, Miquel Serra-Burriel, Matthias Schwenkglenks, Christine S. Zuern, Leo H Bonati, David Conen, Stefan Osswald, Michael Kühne
Institutions: University of Basel, University Hospital of Basel, University of Bern, University Hospital of Bern, Kantonsspital St. Gallen, Istituto Cardiocentro Ticino, Ospedale regionale di Lugano, Luzerner Kantonsspital, University of Zurich, Population Health Research Institute, McMaster University
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: atrial fibrillation, pulmonary vein isolation, catheter ablation, cardiovascular events, all-cause mortality, heart failure hospitalization, stroke, myocardial infarction, hemorrhage, rhythm control, coarsened exact matching, propensity score matching, bleeding risk stratification, stroke risk reduction
Open Access status: hybrid
Estimated APC paid: $3,990
Funders: National Science Foundation, Pfizer, Foundation for Cardiovascular Research, Universität Basel, Boston Scientific Corporation, McMaster University, Mach-Gaensslen Foundation of Canada, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Schweizerische Herzstiftung, Servier, Daiichi Sankyo Europe
OpenAlex ID: W4223604580
